Answer
Avonex (interferon beta-1a) is indicated for adults with relapsing multiple sclerosis, characterised in trials by at least two relapses in the previous three years without continuous progression between relapses; it should be discontinued if progressive MS develops.
Sources for this answer
- AVONEX 30 micrograms/0.5 ml solution for injection.Biogen Idec Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 34Document updated
Sources checked